Log in to save to my catalogue

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8791831

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

About this item

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins
1
,
2
, combined with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, aiming to induce profound SARS-CoV-2 T cell immunity to c...

Alternative Titles

Full title

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8791831

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8791831

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-021-04232-5

How to access this item